Who is sponsoring NCT05676138?

NCT05676138 is sponsored by Seoul National University Hospital.

What drugs are being tested in NCT05676138?

Interventions in NCT05676138: Measuring PK and PD indices in patients who receive conventional treatment.

What condition does NCT05676138 study?

NCT05676138 studies Nontuberculous Mycobacterial Pulmonary Infection.

Is NCT05676138 still recruiting?

NCT05676138 is currently status unknown. Last updated 9 January 2023.

Last reviewed 2023-01-09 · How we verify

NCT05676138

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

PK and PD of Antibiotics for Treatment of Mycobacterium Abscessus Pulmonary Disease

Status unknown Last updated 9 January 2023

What this trial tests

trial testing Measuring PK and PD indices in patients who receive conventional treatment in Nontuberculous Mycobacterial Pulmonary Infection in 40 participants. Status unknown.

Timeline

1 January 2023

Primary endpoint
31 December 2024

31 December 2024

Quick facts

Lead sponsor	Seoul National University Hospital
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	40
Start date	1 January 2023
Primary completion	31 December 2024
Estimated completion	31 December 2024

Drugs / interventions tested

Measuring PK and PD indices in patients who receive conventional treatment

Conditions studied

Nontuberculous Mycobacterial Pulmonary Infection — all drugs for Nontuberculous Mycobacterial Pulmonary Infection →

Sponsor

Seoul National University Hospital

Who can join

20 and older, any sex, with Nontuberculous Mycobacterial Pulmonary Infection. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Investigating the PK and PD indices in patients with M. abscessus complex-PD who will be treated with a currently recommended regimen, minimum inhibitory concentrations of organism, and their relation with clinical outcomes

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Clinical Trials involving <i>Mycobacterium abscessus</i>: An update.
Moore JE, Millar BC. · · 2025 · PMID 40313987

Verify or expand the search:

Other recruiting trials for Nontuberculous Mycobacterial Pulmonary Infection

Currently open trials in the same condition.

NCT06155747 — Transmission and Acquisition of Nontuberculous Mycobacteria Outbreak Investigation (TrANsMIt) · recruiting

Other Seoul National University Hospital trials

Trials by the same sponsor.

NCT07262944 — EOI Block in Otoplasty With Rib Cartilage Graft · NA · recruiting
NCT07464210 — Nemtabrutinib, Bortezomib, and Rituximab for WM · Phase 2 · not yet recruiting
NCT07550803 — Effect of Intraoperative Dexamethasone on Early Postoperative Sleep Quality in Patients Undergoing Nasal Surgery · NA · not yet recruiting
NCT07522138 — Home-based Self-exercise in Patients With Parkinson's Disease: A Feasibility Study · NA · not yet recruiting
NCT07476651 — Scout Dose of Resin Microspheres · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05676138 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Seoul National University Hospital
Last refreshed: 9 January 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05676138.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing